- Home
- PHAT vs TASK Comparison
PHAT vs TASK Comparison
Compare PHAT & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAT | TASK |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.6M | 1.1B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PHAT | TASK |
|---|---|---|
| Price | $14.49 | $11.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $17.33 | $17.20 |
| AVG Volume (30 Days) | ★ 809.7K | 305.2K |
| Earning Date | 10-30-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.76 |
| EPS | N/A | ★ 0.88 |
| Revenue | $147,190,000.00 | ★ $1,144,833,000.00 |
| Revenue This Year | $218.59 | $20.40 |
| Revenue Next Year | $84.38 | $7.85 |
| P/E Ratio | ★ N/A | $13.88 |
| Revenue Growth | ★ 460.30 | 19.88 |
| 52 Week Low | $2.21 | $10.68 |
| 52 Week High | $16.45 | $18.60 |
Technical Indicators
Market Signals| Indicator | PHAT | TASK |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 44.49 |
| Support Level | $14.12 | $12.04 |
| Resistance Level | $16.45 | $12.65 |
| Average True Range (ATR) | 0.74 | 0.32 |
| MACD | -0.12 | 0.16 |
| Stochastic Oscillator | 15.02 | 50.34 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.